Johnson & Johnson News Headlines

JNJ 
$105.06
*  
0.47
0.45%
Get JNJ Alerts
*Delayed - data as of Dec. 26, 2014  -  Find a broker to begin trading JNJ now
Exchange: NYSE
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
The Best Stocks for Retirees
12/28/2014 6:32:03 AM - Motley Fool


Can DGI Aristocrats Beat The Market?
12/26/2014 8:05:00 PM - Seeking Alpha


Seeking Alpha's Biotech Weekly: AbbVie Slaps Gilead, Achillion's 'Nuc' Power, And More
12/26/2014 4:00:00 PM - Seeking Alpha


After Gilead Sciences, Is it Time to Sell Biotech Stocks? - Analyst Blog
12/26/2014 9:25:00 AM - Investopedia


After Gilead Sciences, Is it Time to Sell Biotech Stocks? - Analyst Blog
12/26/2014 9:25:00 AM - Zacks.com


4 Biotech Stocks that Doubled in 2014 - Analyst Blog
12/26/2014 9:00:00 AM - Investopedia


3 Pharma Giants Growing Significantly Faster Than GlaxoSmithKline PLC
12/26/2014 8:02:04 AM - Motley Fool


Can You Retire In Your 50s?
12/26/2014 2:38:00 AM - Seeking Alpha


Don't Worry About Missing The Bottom
12/25/2014 2:41:00 PM - Seeking Alpha


Johnson & Johnson February 2015 Options Begin Trading
12/24/2014 3:04:09 PM - BNK Invest


Integra LifeSciences Hits 52-Week High on Portfolio Strength - Analyst Blog
12/24/2014 1:00:00 PM - Investopedia


Integra LifeSciences Hits 52-Week High on Portfolio Strength - Analyst Blog
12/24/2014 1:00:00 PM - Zacks.com


Amgen Named A Top Socially Responsible Dividend Stock
12/24/2014 9:52:08 AM - BNK Invest


4 Reasons I'm Adding Gilead To My Healthcare Holdings
12/24/2014 7:18:00 AM - Seeking Alpha


Pharmacyclics Reveals FDA Action Date for Imbruvica sNDA - Analyst Blog
12/23/2014 6:05:00 PM - Zacks.com


Achillion Gains on Positive Results from its HCV Candidates - Analyst Blog
12/23/2014 5:00:00 PM - Zacks.com


Express Scripts (ESRX) Picks AbbVie's Hepatitis C Drug - Analyst Blog
12/23/2014 4:50:00 PM - Zacks.com


AbbVie Puts The Hurt On Gilead Sciences, Closes Exclusive Deal With Express Scripts
12/23/2014 4:41:00 PM - Seeking Alpha


My 10 Stocks For A Young Dividend Growth Investor
12/23/2014 3:02:00 PM - Seeking Alpha


MacroGenics Inks Deal with J&J for Blood Cancer Therapy - Analyst Blog
12/23/2014 3:00:00 PM - Zacks.com


This May Be the Fastest-Growing Big Pharma Next Year (Hint: It Isn't Johnson & Johnson)
12/23/2014 7:03:03 AM - Motley Fool


Pharmacyclics Reveals FDA Action Date for Imbruvica sNDA - Analyst Blog
12/23/2014 6:05:00 AM - Investopedia


Achillion Gains on Positive Results from its HCV Candidates - Analyst Blog
12/23/2014 5:00:00 AM - Investopedia


Express Scripts (ESRX) Picks AbbVie's Hepatitis C Drug - Analyst Blog
12/23/2014 4:50:00 AM - Investopedia


MacroGenics Inks Deal with J&J for Blood Cancer Therapy - Analyst Blog
12/23/2014 3:00:00 AM - Investopedia